This inventor holds 3 USPTO granted patents. Top assignee: Sankyo Company, Limited. Active years: 2006-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mino, JP (2006 - 2008)
- Minoh, JP (2011)
Company Filing History:
Years Active: 2006-2011
Title: The Innovations of Shinji Tamura
Introduction
Shinji Tamura is a notable inventor based in Mino, Japan. He has made significant contributions to the field of medical science, particularly in the development of anti-tumor agents and liver regeneration promoting agents. With a total of 3 patents to his name, Tamura's work has the potential to impact cancer treatment and liver health.
Latest Patents
One of Tamura's latest patents is an anti-tumor agent that utilizes adiponectin as an active ingredient. This innovative agent is designed to inhibit carcinogenesis in the liver, providing a new approach to cancer treatment. The administration of this agent can be done orally through tablets or parenterally via injection, with specific dosages recommended for intravenous use. Another significant patent focuses on a liver regeneration promoting agent, which elucidates the effects of adiponectin on hepatic stellate cells. This invention demonstrates that adiponectin can suppress hepatic fibrosis and promote the proliferation of normal hepatocytes, showcasing its potential in liver disease management.
Career Highlights
Shinji Tamura is associated with Sankyo Company, Limited, where he continues to advance his research and innovations. His work has garnered attention in the medical community, particularly for its implications in cancer therapy and liver health.
Collaborations
Tamura has collaborated with notable colleagues such as Yuji Matsuzawa and Tohru Funahashi. Their combined expertise has contributed to the development of groundbreaking medical solutions.
Conclusion
Shinji Tamura's contributions to the field of medical science through his patents highlight the importance of innovation in addressing critical health issues. His work with adiponectin presents promising avenues for cancer treatment and liver regeneration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
